Pay in 4 interest-free payments of $6.01 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
The study was approved by the independent Institutional Review Board of each study center (XC11MINT0108K)
SUSTAIN-7 (N=1,201) compared semaglutide 0.5 mg and 1.0 mg against dulaglutide 0.75 mg and 1.5 mg over 40 weeks
This can damage the medicine
Reviews published in 2024 and 2025 also note growing interest in GLP-1 medications across rheumatology, especially for inflammatory arthritis and psoriasis
Stop fighting biology
US$ 21.92
US$ 22.55
US$ 24.11
US$ 29.23
